United States Biotechnology & Medical Research

Euthymics Bioscience Inc (DOVP)

Track

Track

Ticker: DOVP Exchange: PKN
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
276.44
Quantity 86,984 -9.6%
Value US$3,685,174
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
263.81
Quantity 8,815 +33.1%
Value US$3,687,111
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
301.92
Quantity 64,666 -9.2%
Value US$3,962,956
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 10,000 +1.7%
Value US$370
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 1,330 +0.2%
Value US$49
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 51,500 +9.7%
Value US$1,906
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 7,051 +1.3%
Value US$261
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 200,000 +61.5%
Value US$7,000
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 10,495 +4.9%
Value US$378
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 75,826 +54.6%
Value US$2,730
Zakrzewski Joseph S Non-Executive Director
Transaction date
Purchase
Price
0.04
Quantity 1,000 +0.7%
Value US$36
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Purchase
Price
0.05
Quantity 100,000 +263.2%
Value US$5,300
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Purchase
Price
0.07
Quantity 13,800 +55.4%
Value US$966
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Purchase
Price
0.20
Quantity 25,000 +inf%
Value US$5,000
Ashe Patrick Non-Executive Director
Transaction date
Purchase
Price
2.32
Quantity 45,000 +inf%
Value US$104,400
Myers Scott Dunseth Senior Vice President Officer
Transaction date
Purchase
Price
2.69
Quantity 5,000 +100.0%
Value US$13,450
Myers Scott Dunseth Senior Vice President Officer
Transaction date
Purchase
Price
2.69
Quantity 5,000 +inf%
Value US$13,450
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
3.25
Quantity 258,858 -50.1%
Value US$841,288
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
3.25
Quantity 11,422 -50.0%
Value US$37,122
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
3.25
Quantity 547,491 -50.0%
Value US$1,779,346
Skolnick Phil Sr. V.P. Research, CSO Officer
Transaction date
Planned sale
Price
16.05
Quantity 5,000 -100.0%
Value US$80,260
HOROVITZ ZOLA P Non-Executive Director
Transaction date
Planned sale
Price
17.43
Quantity 12,400 -19.8%
Value US$216,085
DOV PHARMACEUTICAL INC SVP & CSO Officer
Transaction date
Planned sale
Price
19.42
Quantity 2,000 -100.0%
Value US$38,840
DOV PHARMACEUTICAL INC SVP & CSO Officer
Transaction date
Planned sale
Price
19.43
Quantity 1,000 -33.3%
Value US$19,430
DOV PHARMACEUTICAL INC SVP & CSO Officer
Transaction date
Planned sale
Price
19.40
Quantity 2,000 -40.0%
Value US$38,800
DOV PHARMACEUTICAL INC SVP & CSO Officer
Transaction date
Planned sale
Price
19.30
Quantity 5,000 -50.0%
Value US$96,500
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
19.00
Quantity 21,700 -46.5%
Value US$412,300
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
19.01
Quantity 1,900 -3.9%
Value US$36,119
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
19.02
Quantity 1,400 -2.8%
Value US$26,628
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Planned sale
Price
18.00
Quantity 316,200 -41.9%
Value US$5,691,600
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Planned sale
Price
18.01
Quantity 200 -0.0%
Value US$3,602
DOV PHARMACEUTICAL INC SVP & CSO Officer
Transaction date
Planned sale
Price
18.05
Quantity 30,000 -100.0%
Value US$541,500
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
18.00
Quantity 20,000 -44.4%
Value US$360,000
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Planned sale
Price
18.10
Quantity 300 -0.0%
Value US$5,430
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.00
Quantity 1,600 -100.0%
Value US$27,200
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.01
Quantity 100 -5.9%
Value US$1,701
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.02
Quantity 400 -19.0%
Value US$6,808
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.03
Quantity 100 -4.5%
Value US$1,703
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.05
Quantity 2,300 -51.1%
Value US$39,215
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.10
Quantity 2,200 -32.8%
Value US$37,620
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.11
Quantity 1,000 -13.0%
Value US$17,110
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.12
Quantity 2,300 -23.0%
Value US$39,376
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.13
Quantity 600 -5.7%
Value US$10,278
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.14
Quantity 1,400 -11.7%
Value US$23,996
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.15
Quantity 1,000 -7.7%
Value US$17,150
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.16
Quantity 1,600 -11.0%
Value US$27,456
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.17
Quantity 200 -1.4%
Value US$3,434
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.18
Quantity 100 -0.7%
Value US$1,718
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.19
Quantity 1,500 -9.1%
Value US$25,785
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.20
Quantity 2,600 -13.7%
Value US$44,720
DOV PHARMACEUTICAL INC SVP & CFO Officer
Transaction date
Planned sale
Price
17.21
Quantity 1,000 -5.0%
Value US$17,210
DOV PHARMACEUTICAL INC S.V.P. & CSO Officer
Transaction date
Planned sale
Price
15.82
Quantity 5,000 -100.0%
Value US$79,100
DOV PHARMACEUTICAL INC Sr. V.P. & C.S.O. Officer
Transaction date
Planned sale
Price
15.90
Quantity 5,000 -100.0%
Value US$79,500
DOV PHARMACEUTICAL INC Sr. V.P. & C.S.O. Officer
Transaction date
Planned sale
Price
15.82
Quantity 5,000 -50.0%
Value US$79,100
DOV PHARMACEUTICAL INC Sr. V.P. Research, CSO Officer
Transaction date
Planned sale
Price
15.82
Quantity 5,000 -100.0%
Value US$79,100
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.27
Quantity 83,300 -9.9%
Value US$1,271,991
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.07
Quantity 79,500 -8.7%
Value US$1,197,970
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.27
Quantity 37,200 -3.9%
Value US$567,951
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Planned sale
Price
14.52
Quantity 10,500 -17.3%
Value US$152,500
DOV PHARMACEUTICAL INC Sr. V.P. Research, CSO Officer
Transaction date
Planned sale
Price
16.88
Quantity 5,000 -100.0%
Value US$84,400
DOV PHARMACEUTICAL INC Sr. V.P. & CSO Officer
Transaction date
Planned sale
Price
15.82
Quantity 5,000 -100.0%
Value US$79,100
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Planned sale
Price
18.00
Quantity 33,300 -3.4%
Value US$599,400
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Planned sale
Price
18.17
Quantity 15,000 -23.0%
Value US$272,510
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
18.24
Quantity 138,400 -6.4%
Value US$2,524,416
ORBIMED ADVISORS LLC Non-Executive Director
Transaction date
Sale
Price
18.47
Quantity 85,000 -3.8%
Value US$1,569,950
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
18.30
Quantity 2,500 -4.7%
Value US$45,750
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
18.02
Quantity 2,500 -4.5%
Value US$45,050
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
18.00
Quantity 2,500 -4.3%
Value US$45,000
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
17.96
Quantity 7,500 -11.5%
Value US$134,700
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.67
Quantity 3,150 -100.0%
Value US$49,360
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.66
Quantity 3,000 -48.8%
Value US$46,980
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.65
Quantity 2,500 -28.9%
Value US$39,125
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.68
Quantity 2,500 -22.4%
Value US$39,200
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
15.66
Quantity 1,000 -8.2%
Value US$15,660
DOV PHARMACEUTICAL INC Non-Executive Director
Transaction date
Sale
Price
16.46
Quantity 21,000 -29.5%
Value US$345,660
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-11-21 2008-11-19 B Purchase Zakrzewski Joseph S Non-Executive Director
86,984 -9.6%
276.44
US$3,685,174 		86,984 -9.6% 276.44 US$3,685,174
2008-10-08 2008-09-30 B Purchase Zakrzewski Joseph S Non-Executive Director
8,815 +33.1%
263.81
US$3,687,111 		8,815 +33.1% 263.81 US$3,687,111
2008-09-15 2008-09-15 B Purchase Zakrzewski Joseph S Non-Executive Director
64,666 -9.2%
301.92
US$3,962,956 		64,666 -9.2% 301.92 US$3,962,956
2008-09-15 2008-09-12 B Purchase Zakrzewski Joseph S Non-Executive Director
10,000 +1.7%
0.04
US$370 		10,000 +1.7% 0.04 US$370
2008-09-09 2008-09-09 B Purchase Zakrzewski Joseph S Non-Executive Director
1,330 +0.2%
0.04
US$49 		1,330 +0.2% 0.04 US$49
2008-09-09 2008-09-08 B Purchase Zakrzewski Joseph S Non-Executive Director
51,500 +9.7%
0.04
US$1,906 		51,500 +9.7% 0.04 US$1,906
2008-09-09 2008-09-05 B Purchase Zakrzewski Joseph S Non-Executive Director
7,051 +1.3%
0.04
US$261 		7,051 +1.3% 0.04 US$261
2008-09-02 2008-08-27 B Purchase Zakrzewski Joseph S Non-Executive Director
200,000 +61.5%
0.04
US$7,000 		200,000 +61.5% 0.04 US$7,000
2008-07-18 2008-07-16 B Purchase Zakrzewski Joseph S Non-Executive Director
10,495 +4.9%
0.04
US$378 		10,495 +4.9% 0.04 US$378
2008-07-01 2008-06-30 B Purchase Zakrzewski Joseph S Non-Executive Director
75,826 +54.6%
0.04
US$2,730 		75,826 +54.6% 0.04 US$2,730
2008-07-01 2008-06-27 B Purchase Zakrzewski Joseph S Non-Executive Director
1,000 +0.7%
0.04
US$36 		1,000 +0.7% 0.04 US$36
2008-04-08 2008-04-03 B Purchase DOV PHARMACEUTICAL INC Non-Executive Director
100,000 +263.2%
0.05
US$5,300 		100,000 +263.2% 0.05 US$5,300
2008-01-17 2008-01-09 B Purchase DOV PHARMACEUTICAL INC Non-Executive Director
13,800 +55.4%
0.07
US$966 		13,800 +55.4% 0.07 US$966
2007-09-10 2007-09-07 B Purchase DOV PHARMACEUTICAL INC Non-Executive Director
25,000 +inf%
0.20
US$5,000 		25,000 +inf% 0.20 US$5,000
2006-07-10 2006-07-07 B Purchase Ashe Patrick Non-Executive Director
45,000 +inf%
2.32
US$104,400 		45,000 +inf% 2.32 US$104,400
2006-05-26 2006-05-25 B Purchase Myers Scott Dunseth

Senior Vice President

Officer
5,000 +100.0%
2.69
US$13,450 		5,000 +100.0% 2.69 US$13,450
2006-05-26 2006-05-24 B Purchase Myers Scott Dunseth

Senior Vice President

Officer
5,000 +inf%
2.69
US$13,450 		5,000 +inf% 2.69 US$13,450
2006-05-18 2006-05-16 S Sale ORBIMED ADVISORS LLC Non-Executive Director
258,858 -50.1%
3.25
US$841,288 		258,858 -50.1% 3.25 US$841,288
2006-05-18 2006-05-16 S Sale ORBIMED ADVISORS LLC Non-Executive Director
11,422 -50.0%
3.25
US$37,122 		11,422 -50.0% 3.25 US$37,122
2006-05-18 2006-05-16 S Sale ORBIMED ADVISORS LLC Non-Executive Director
547,491 -50.0%
3.25
US$1,779,346 		547,491 -50.0% 3.25 US$1,779,346
2006-04-05 2006-04-03 PlS Planned sale Skolnick Phil

Sr. V.P. Research, CSO

Officer
5,000 -100.0%
16.05
US$80,260 		5,000 -100.0% 16.05 US$80,260
2006-03-15 2006-03-13 PlS Planned sale HOROVITZ ZOLA P Non-Executive Director
12,400 -19.8%
17.43
US$216,085 		12,400 -19.8% 17.43 US$216,085
2006-03-02 2006-03-01 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CSO

Officer
2,000 -100.0%
19.42
US$38,840 		2,000 -100.0% 19.42 US$38,840
2006-03-02 2006-03-01 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CSO

Officer
1,000 -33.3%
19.43
US$19,430 		1,000 -33.3% 19.43 US$19,430
2006-03-02 2006-03-01 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CSO

Officer
2,000 -40.0%
19.40
US$38,800 		2,000 -40.0% 19.40 US$38,800
2006-03-02 2006-03-01 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CSO

Officer
5,000 -50.0%
19.30
US$96,500 		5,000 -50.0% 19.30 US$96,500
2006-02-13 2006-02-13 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
21,700 -46.5%
19.00
US$412,300 		21,700 -46.5% 19.00 US$412,300
2006-02-13 2006-02-13 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,900 -3.9%
19.01
US$36,119 		1,900 -3.9% 19.01 US$36,119
2006-02-13 2006-02-13 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,400 -2.8%
19.02
US$26,628 		1,400 -2.8% 19.02 US$26,628
2006-02-13 2006-02-09 PlS Planned sale DOV PHARMACEUTICAL INC Non-Executive Director
316,200 -41.9%
18.00
US$5,691,600 		316,200 -41.9% 18.00 US$5,691,600
2006-02-13 2006-02-09 PlS Planned sale DOV PHARMACEUTICAL INC Non-Executive Director
200 -0.0%
18.01
US$3,602 		200 -0.0% 18.01 US$3,602
2006-02-13 2006-02-09 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CSO

Officer
30,000 -100.0%
18.05
US$541,500 		30,000 -100.0% 18.05 US$541,500
2006-02-13 2006-02-09 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
20,000 -44.4%
18.00
US$360,000 		20,000 -44.4% 18.00 US$360,000
2006-02-13 2006-02-09 PlS Planned sale DOV PHARMACEUTICAL INC Non-Executive Director
300 -0.0%
18.10
US$5,430 		300 -0.0% 18.10 US$5,430
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,600 -100.0%
17.00
US$27,200 		1,600 -100.0% 17.00 US$27,200
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
100 -5.9%
17.01
US$1,701 		100 -5.9% 17.01 US$1,701
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
400 -19.0%
17.02
US$6,808 		400 -19.0% 17.02 US$6,808
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
100 -4.5%
17.03
US$1,703 		100 -4.5% 17.03 US$1,703
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
2,300 -51.1%
17.05
US$39,215 		2,300 -51.1% 17.05 US$39,215
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
2,200 -32.8%
17.10
US$37,620 		2,200 -32.8% 17.10 US$37,620
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,000 -13.0%
17.11
US$17,110 		1,000 -13.0% 17.11 US$17,110
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
2,300 -23.0%
17.12
US$39,376 		2,300 -23.0% 17.12 US$39,376
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
600 -5.7%
17.13
US$10,278 		600 -5.7% 17.13 US$10,278
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,400 -11.7%
17.14
US$23,996 		1,400 -11.7% 17.14 US$23,996
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,000 -7.7%
17.15
US$17,150 		1,000 -7.7% 17.15 US$17,150
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,600 -11.0%
17.16
US$27,456 		1,600 -11.0% 17.16 US$27,456
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
200 -1.4%
17.17
US$3,434 		200 -1.4% 17.17 US$3,434
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
100 -0.7%
17.18
US$1,718 		100 -0.7% 17.18 US$1,718
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,500 -9.1%
17.19
US$25,785 		1,500 -9.1% 17.19 US$25,785
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
2,600 -13.7%
17.20
US$44,720 		2,600 -13.7% 17.20 US$44,720
2006-02-07 2006-02-03 PlS Planned sale DOV PHARMACEUTICAL INC

SVP & CFO

Officer
1,000 -5.0%
17.21
US$17,210 		1,000 -5.0% 17.21 US$17,210
2006-02-03 2006-02-01 PlS Planned sale DOV PHARMACEUTICAL INC

S.V.P. & CSO

Officer
5,000 -100.0%
15.82
US$79,100 		5,000 -100.0% 15.82 US$79,100
2006-01-12 2006-01-10 PlS Planned sale DOV PHARMACEUTICAL INC

Sr. V.P. & C.S.O.

Officer
5,000 -100.0%
15.90
US$79,500 		5,000 -100.0% 15.90 US$79,500
2006-01-12 2006-01-10 PlS Planned sale DOV PHARMACEUTICAL INC

Sr. V.P. & C.S.O.

Officer
5,000 -50.0%
15.82
US$79,100 		5,000 -50.0% 15.82 US$79,100
2005-11-09 2005-11-07 PlS Planned sale DOV PHARMACEUTICAL INC

Sr. V.P. Research, CSO

Officer
5,000 -100.0%
15.82
US$79,100 		5,000 -100.0% 15.82 US$79,100
2005-11-04 2005-11-04 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
83,300 -9.9%
15.27
US$1,271,991 		83,300 -9.9% 15.27 US$1,271,991
2005-11-04 2005-11-03 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
79,500 -8.7%
15.07
US$1,197,970 		79,500 -8.7% 15.07 US$1,197,970
2005-11-04 2005-11-02 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
37,200 -3.9%
15.27
US$567,951 		37,200 -3.9% 15.27 US$567,951
2005-10-21 2005-10-17 PlS Planned sale DOV PHARMACEUTICAL INC Non-Executive Director
10,500 -17.3%
14.52
US$152,500 		10,500 -17.3% 14.52 US$152,500
2005-10-04 2005-10-03 PlS Planned sale DOV PHARMACEUTICAL INC

Sr. V.P. Research, CSO

Officer
5,000 -100.0%
16.88
US$84,400 		5,000 -100.0% 16.88 US$84,400
2005-09-09 2005-09-07 PlS Planned sale DOV PHARMACEUTICAL INC

Sr. V.P. & CSO

Officer
5,000 -100.0%
15.82
US$79,100 		5,000 -100.0% 15.82 US$79,100
2005-08-29 2005-08-25 PlS Planned sale DOV PHARMACEUTICAL INC Non-Executive Director
33,300 -3.4%
18.00
US$599,400 		33,300 -3.4% 18.00 US$599,400
2005-08-17 2005-08-15 PlS Planned sale DOV PHARMACEUTICAL INC Non-Executive Director
15,000 -23.0%
18.17
US$272,510 		15,000 -23.0% 18.17 US$272,510
2005-08-16 2005-08-15 S Sale ORBIMED ADVISORS LLC Non-Executive Director
138,400 -6.4%
18.24
US$2,524,416 		138,400 -6.4% 18.24 US$2,524,416
2005-08-16 2005-08-12 S Sale ORBIMED ADVISORS LLC Non-Executive Director
85,000 -3.8%
18.47
US$1,569,950 		85,000 -3.8% 18.47 US$1,569,950
2005-06-28 2005-06-27 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
2,500 -4.7%
18.30
US$45,750 		2,500 -4.7% 18.30 US$45,750
2005-06-28 2005-06-27 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
2,500 -4.5%
18.02
US$45,050 		2,500 -4.5% 18.02 US$45,050
2005-06-28 2005-06-27 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
2,500 -4.3%
18.00
US$45,000 		2,500 -4.3% 18.00 US$45,000
2005-06-28 2005-06-27 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
7,500 -11.5%
17.96
US$134,700 		7,500 -11.5% 17.96 US$134,700
2005-05-17 2005-05-16 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
3,150 -100.0%
15.67
US$49,360 		3,150 -100.0% 15.67 US$49,360
2005-05-17 2005-05-16 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
3,000 -48.8%
15.66
US$46,980 		3,000 -48.8% 15.66 US$46,980
2005-05-17 2005-05-16 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
2,500 -28.9%
15.65
US$39,125 		2,500 -28.9% 15.65 US$39,125
2005-05-17 2005-05-16 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
2,500 -22.4%
15.68
US$39,200 		2,500 -22.4% 15.68 US$39,200
2005-05-17 2005-05-16 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
1,000 -8.2%
15.66
US$15,660 		1,000 -8.2% 15.66 US$15,660
2004-11-12 2004-11-08 S Sale DOV PHARMACEUTICAL INC Non-Executive Director
21,000 -29.5%
16.46
US$345,660 		21,000 -29.5% 16.46 US$345,660
Explore more

More insider trading research around Euthymics Bioscience Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America